Compression Therapy Market, by Technology (Static Compression Therapy, and Dynamic Compression Therapy), by Product Type (Compression Garments, Compression Stockings, Compression Bandages, Compression Tapes, and Compression Pumps), by Application (Varicose Vein, Deep Vein Thrombosis, Lymphedema, and Leg Ulcer), by Distribution Channel (Pharmacies, E-Commerce, and Others (Speciality Stores, Supermarkets, etc.)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In : Jul 2022

Code : CMI544

Pages :340

Formats :

Excel and PDF

Industry : Medical Devices

Compression Therapy MarketSize and Trends

Compression therapy market is estimated to be valued at US$ 3,336.4 million in 2022 and is expected to exhibit a CAGR of 5.9 % over the forecast period (2022-2030)

Figure 1. Global Compression Therapy Market Value (US$ Mn), By Region, 2022

Increasing venous diseases patients worldwide is expected to drive growth of the global compression therapy market over the forecast period.

For instance, according to an article published in Annals of Vascular Surgery in December 2021, a total of 869,220 surgeries were performed to treat chronic venous diseases over twelve years of span from 2008-2019 in Brazil, with an overall rate of 4.52 procedures per 10,000 population per year.

Figure 2. Global Compression Therapy Market Share (%), By Product Type, 2022

Increasing product launches and approvals are expected to drive market growth over the forecast period.

For instance, in April 2018 Tactile Systems Technology, Inc. a company which develops and markets at home therapy devices that treat lymphedema and chronic venous insufficiency had launched next generation Flexitouch system: Flexitouch plus. Flexitouch plus was the third generation of the company’s Flexitouch system and featured several key enhancements over prior generations, specifically the Flexitouch plus system’s controller, which had enhanced with a color display, the systems enhanced controller also enabled patients to treat two legs simultaneously, allowing them to complete bilateral therapy in less time. Moreover, the Flexitouch plus systems garments had been redesigned to provide improved fit, comfort and coverage and allow patients to wear it easily.

Moreover, AIROS Medical, Inc., a medical technology manufacturer specializing in compression therapy products, announced the launch of its updated AIROS 6 Sequential Compression Therapy device and Arm Plus garments (U.S. Food and Drug Administration (FDA) 510(k) cleared). The AIROS 6 uses pneumatic air compression to inflate accessory garments worn on the affected area of the body. It is used for the treatment of lymphedema in the arm, shoulder, chest, and back.